Michael Scolaro

Michael Scolaro

Sep 10, 2017

Group 6 Copy 191
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia

    Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...

    A scientific approach to placenta remedies: What hormones are found in placenta tissue?

    The human placenta contains a mixture of substances which may be useful for individual postpartum treatment...

    Identification of Pancreatic Cancer Specific Tumor Markers for Early Detection

    Pancreatic cancer is the third leading cause of cancer-related death in the US, and expected to become the...

    Backer Badge Funded